Cargando…

T cells instruct myeloid cells to produce inflammasome-independent IL-1β and cause autoimmunity

The cytokine interleukin-1β (IL-1β) is a key mediator of anti-microbial immunity as well as autoimmune inflammation. Production of IL-1β requires transcription by innate immune receptor signaling and maturational cleavage by inflammasomes. Whether this mechanism applies to IL-1β production seen in T...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Aakanksha, Irizarry-Caro, Ricardo A., McDaniel, Margaret M., Chawla, Amanpreet Singh, Carroll, Kaitlin R., Overcast, Garrett R., Philip, Naomi H., Oberst, Andrew, Chervonsky, Alexander V., Katz, Jonathan D., Pasare, Chandrashekhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927526/
https://www.ncbi.nlm.nih.gov/pubmed/31848486
http://dx.doi.org/10.1038/s41590-019-0559-y
Descripción
Sumario:The cytokine interleukin-1β (IL-1β) is a key mediator of anti-microbial immunity as well as autoimmune inflammation. Production of IL-1β requires transcription by innate immune receptor signaling and maturational cleavage by inflammasomes. Whether this mechanism applies to IL-1β production seen in T cell-driven autoimmune diseases remains unclear. Here, we describe an inflammasome-independent pathway of IL-1β production that was triggered upon cognate interactions between effector CD4(+) T cells and mononuclear phagocytes (MPs). The cytokine TNF produced by activated CD4(+) T cells engaged its receptor TNFR on MPs, leading to pro-IL-1β synthesis. Membrane-bound FasL, expressed by CD4(+) T cells, activated death receptor Fas signaling in MPs resulting in caspase-8-dependent pro-IL-1β cleavage. The T cell-instructed IL-1β resulted in systemic inflammation, while absence of TNFR or Fas signaling protected mice from CD4(+) T cell-driven autoimmunity. The TNFR-Fas-caspase-8-dependent pathway provides a mechanistic explanation for IL-1β production and its consequences in CD4(+) T cell-driven autoimmune pathology.